Prof. Dr. Dieter Willbold
Full Professor for “Physical Biology” at the Heinrich Heine University in Düsseldorf and Director at the Institute of Complex Systems, Structural Biochemistry (ICS-6) at the Forschungszentrum Jülich,
is biochemist, biophysicist, structural biologist, and a long-standing expert in the field of AD.
He developed the innovative treatment strategy to target severe neurodegenerative disorders and is
coinventor of multiple novel drug candidates. Prof. Dr. Willbold has profound expertise in the technology platform applied to identify and optimize D-peptide based drug candidates for the treatment of neurological disorders with high medical needs.